A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD

Clinical trial NCT03950882 · COMPLETED

Trial details

NCT number: NCT03950882
Sponsor: Poxel SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver

Start date: 2019-08-01
Primary completion: 2020-03-29
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.